Equity Research, Broker Reports, and media content on Beximco Pharmaceuticals Limited Sponsored GDR RegS

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about Beximco Pharmaceuticals Limited Sponsored GDR RegS
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard

Beximco Pharmaceuticals Limited Sponsored GDR RegS

Company Profile

  • Personnel
  • Ahmed Sohail Fasiur Rahman, Chairman
  • Nazmul Hassan, CEO
  • Ali Nawaz, CFO

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on Beximco Pharmaceuticals Limited Sponsored GDR RegS. We currently have 65 research reports from 3 professional analysts.

  • Open: N/A
  • Range Today: N/A
  • 52 Week: 65.0/112p
  • Daily Volume: N/A
  • Daily Liquidity: (0.00%)
  • # Shares: 446.1m
  • Market Cap: £455.0m
  • Latest PE (hist): 0.00
  • Div Yield: 1.92
Date Source Announcement
02Dec21 07:00 RNS Beximco Pharmaceut - Update on the supply of COVID-19 vaccine
24Nov21 07:43 RNS Beximco Pharmaceut - Statement re: media comment
16Nov21 07:00 RNS Beximco Pharmaceut - Notice of AGM
11Nov21 10:30 RNS Beximco Pharmaceut - Results for First Quarter Ended 30 September 2021
09Nov21 07:00 RNS Beximco Pharmaceut - Launch of world’s first generic molnupiravir
02Nov21 07:00 RNS Beximco Pharmaceut - Results for the year ended 30 June 2021
21Oct21 12:36 RNS Beximco Pharmaceut - Notification of Preliminary Results and AGM
  • Frequency of research reports

     

  • Research reports on

    Beximco Pharmaceuticals Limited Sponsored GDR RegS

  • Providers covering

    Beximco Pharmaceuticals Limited Sponsored GDR RegS